EcoDrugPlus

Kinesin Family Member 5b

Ensembl ID : ENSCSEG00000014089
Gene Symbol: KIF5B
4 Cross references
243 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSCSEG00000006012
Gene Symbol: LTA4H
3 Cross references
205 Possible Orthologues:

Leukotriene B4 Receptor 1

Ensembl ID : ENSCSEG00000021337
Gene Symbol: LOC103396728
3 Cross references
167 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSCSEG00000020074
Gene Symbol: LOC103385870
3 Cross references
159 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSCSEG00000002808
Gene Symbol: KDM1A
3 Cross references
214 Possible Orthologues:

Lysyl Oxidase Homolog 2a-Like

Ensembl ID : ENSCSEG00000005731
Gene Symbol: LOC103386215
3 Cross references
208 Possible Orthologues:

Lysyl Oxidase Homolog 2b-Like

Ensembl ID : ENSCSEG00000013648
Gene Symbol: LOC103397414
3 Cross references
213 Possible Orthologues:

Macrophage Colony-Stimulating Factor 1 Receptor 2-Like

Ensembl ID : ENSCSEG00000020459
Gene Symbol: LOC103395736
2 Cross references
199 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSCSEG00000006641
Gene Symbol: MIF
3 Cross references
235 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSCSEG00000000547
Gene Symbol: MST1R
3 Cross references
196 Possible Orthologues:

Macrophage-Stimulating Protein Receptor-Like

Ensembl ID : ENSCSEG00000008213
Gene Symbol: LOC103386279
2 Cross references
194 Possible Orthologues:

Mast/stem Cell Growth Factor Receptor Kita-Like

Ensembl ID : ENSCSEG00000006569
Gene Symbol: LOC103383759
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).